References
- 1. Mebs D. Venomous and Poisonous Animals. A Handbook for Biologists, Toxicologists and Toxinologists, Physicians and Pharmacists. 1st Ed. Medpharm Scientific Publisher, Boca Raton: Stuttgart, Germany CRC Press. 2002:2.
- 2. Karmakar RN. Forensic Medicine and Toxicology, Oral, Practical & M.C.Q. 3rd Edition. Academic Publishers, Published by Bimal Kumar Dhur, Kolkta, India. 2010:57.
- 3. http://www.toxinology.org/
- 4. Birell GW, Earl S, Masci P. et al. Molecular diversity in venom from the Australian Brown snake, Pseudonaja textilis. Mol Cell Proteomics. 2006;5:379-389.
- 5. Calvete JJ, Juarez P, Sanz L. Snake venomics, strategy and applications. J Mass Spectrom. 2007;42:1405-1414.
- 6. Smith CG, Vane JR. The discovery of captopril. FASEB (Fed Am Soc Exp Biol) J. 2003;17:799-789.
- 7. Bryan J. From snake venom to ACE inhibitor. The discovery and rise of captopril. Pharm J. 2009;282:455-456.
- 8. Chippaux JP, Williams V, White J. Snake venom variability: methods of study, results and interpretation. Toxicon. 1991;29:1279-1303.
- 9. Bas M, Adams V, Suvorava T. Nonallergic angioedema; role of bradykinin. Allergy. 2007;62:842-856.
- 10. Craik DJ, Schroeder CI. Peptides from Mamba Venom as Pain Killers. Angew Chem Int Ed. 2013;52:3071-3073.
- 11. Shanbhag VKL. Applications of snake venoms in treatment of cancer. Asian Pac J Trop Biomed. 2015;5(4):275-276.
- 12. Vyas VK, Brahmbhatt K, Bhatt H, Parmar U. Therapeutic potential of snake venom in cancer therapy: current perspectives. Asian Pac J Trop Biomed. 2013;3(2):156-162.
- 13. Finn R. Snake venom protein paralyzes cancer cells. J Natl Cancer Inst. 2001;93(4):261-262.
- 14. Al-Sadoon M, Rabah DM, Badr G. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: Molecular targets for cell cycle arrest and apoptosis induction. Cell Immunol. 2013;284:129-136.
- 15. El-Refael M, Sarkar N. Snake venom inhibits the growth of mouse mammary tumor cells in vitro and in vivo. Toxicon. 2009;54:33-41.
- 16. Das T, Bhattacharya S, Biswas A. Inhibition of leukemic U937 cell growth by induction of apoptosis, cell cycle arrest and suppression of VEGF, MMP-2 and MMP-9 activities by cytotoxin protein NN-32 purified from Indian spectacled cobra (Naja naja) venom. Toxicon. 2013;65:1-4.
- 17. Gordaliza M. Natural products as leads to anticancer drugs. Clin Trans Oncol. 2007;9:767-776.
- 18. Samy RP, Chow VTK et al. Antimicrobial Proteins from Snake Venoms: Direct Bacterial Damage and Activation of Innate Immunity against Staphylococcus aureus Skin Infection. Curr. Med. Chem. 2011;18(33):5104-5113.
- 19. Costa Torres AF, Dantas RT, Toyama MH et al. Antibacterial and antiparasitic effects of Bothrops marajoensis venom and its fractions: phosholipase A2 and L-amino acid oxidase. Toxicon, 2010;55:795-804.
- 20. Nair DG, Fry BG, Alewood P et al. Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. J Biol Chem. 2007;402:93-104;
- 21. Fenard D, Lambeau G, Valentin E et al. Secreted phospholipases A(2), a new class of HIV inhibitors that block virus entry into host cells. J Clin Invest. 1999;104:611-618.
- 22. Samy RP, Thong TWJ et al. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes. J Appl Micriobiol. 2007;102:650-659.
- 23. Ständker L, Harvey AL, Béress L. et al. Improved method for the isolation, characterization and examination of neuromuscular and toxic properties of selected polypeptide fractions from the crude venom of the Taiwan cobra Naja naja atra. Toxicon 2012;60:623-631.
- 24. Zaqueo KD, Kayano AM, Stábeli RG et al. Isolation and biochemical characterization of a new thrombin-like serine protease from Bothrops pirajai snake venom. Biomed Res Int. 2014;2014:1-13.
- 25. Angulo Y, Castro A, Gutiérrez JM et al. Isolation and characterization of four medium-size disintegrins from the venom of Central American viperid snakes of the genera Antropoides, Bothrops, Cerrophidion and Crotalus. Biochemie 2014,107:376-384.
- 26. Hanane-Ziad-Meziane HF, Laraba-Djebari F. Purification, characterization and antibacterial activity of L-amino acid oxidase from Cerastes cereastes. J. Biochem. Mol. Toxic. 2014,28:347-354.
- 27. Nunes ES, Correia MTS et al. Purification of lectin with antibacterial activity from Bothrops leucurus snake venom. Comp. Biochem. Physiol., B: Comp. Biochem. 2011,159:57-63.
- 28. El Hakim AE, Abouelella AMK et al. Purification and characterization of a cytotoxic neurotoxin-like protein from Naja Haje haje venom that induces mitochondrial apoptosis pathway. Arch. Toxicol. 2011,85:941-952.
- 29. Botes DP, Strydom DJ. A neurotoxin, toxin alpha, from Egyptian cobra (Naja Haje Haje) venom. I. Purification, properties, and complete amino acid sequence. J. Biol. Chem. 1969;244:4147-4157.
- 30. Wen YL, Wu BJ, Chang LS et al. Antibacterial and membrane-damaging activities of β-bungarotoxin B chain. J Pept Sci. 2012;19:1-8.
- 31. Chen LW, Kao PH, Fu YS, Hu WP, Chang LS. Bactericidal effect of Naja nigricollis toxin γ is related to its membrane damaging activity. Peptides. 2011;32:1755-1763.
- 32. Samy RP, Al Qahtani et al. Sanke venom proteins: Development into Antimicrobial and Wound Healing Agents. Mini Rev Org Chem. 2014;11:4-14.
- 33. Al Ahmadi AJ, Mirakabbadi AZ et al. Investigation of the antibacterial effect of venom of the Iranian snake Echis carinatus. Iran J Vet Sci Technol (IJVST). 2010;2:93-100.
- 34. Jalaei J, Fazeli M, Rajaian H, Shekarforoush SS. In vitro antibacterial effect of wasp (Vespa orientalis) venom. J venom Anim Toxins Incl Trop Dis. 2014;20:1-6.
- 35. Zhao Z, Cao J, Li W et al. Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob Agents Chemother. 2009;53(8):3472-3477.